The Ontario government released a new life sciences strategy last week, and it raises an interesting question about the possibilities of connections between NEO and Ontario in the life sciences. BioEnterprise, I recall from a conversation with brother Hunter, is pursuing ties to Pittsburgh. It may make sense to do the same with Ontario. I leave it to others to connect with BioE to see what’s up.

Here are some highlights from The Cross-Border Biotech Blog (based in Ontario).

At a press conference in London today, Ontario’s Minister of Research and Innovation, John Milloy, is scheduled to announce the Province’s new $161 million Life Sciences Commercialization Strategy.

The bulk of the money ($114 million) is allocated to the Global Leadership Round in Genomics & Life Sciences (GL2), though $100 million of that was announced last year. Recent announcements under this program include $8.1 million for the International Barcode of Life Project, an $8.8 million grant to SickKids for autism genomics research, and $24.8 million to a posse of University of Toronto genomics researchers.

You can download the Ontario commercialization strategy here.

Last 5 posts by Ed Morrison

Random Posts